Antibiotic prophylaxis for onabotulinum toxin A injections: systematic review and meta-analysis

被引:0
作者
Feven W. Getaneh
Rishabh Simhal
Tamir Sholklapper
Emilie Melvin
Charles Scott Dorris
Jiling Chou
Lee A. Richter
Alexis Dieter
机构
[1] MedStar Washington Hospital Center,Department of Obstetrics and Gynecology
[2] Ochsner Health,Department of Urology
[3] Einstein Health,Department of Urology
[4] Penn Medicine,Department of Obstetrics and Gynecology
[5] Georgetown University School of Medicine,Department of Obstetrics and Gynecology and Department of Urology
[6] Medstar Health Research Institute,undefined
[7] MedStar Georgetown Washington Hospital Center,undefined
来源
International Urogynecology Journal | 2024年 / 35卷
关键词
Botox; Anti-bacterial agents; Urinary tract infection; Overactive bladder; Systematic review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:19 / 29
页数:10
相关论文
共 159 条
[1]  
Miotla P(2017)Can Botox improve night-time overactive bladder symptoms in women? Neurourol Urodyn 36 648-652
[2]  
Cartwright R(2016)OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial JAMA 316 1366-1374
[3]  
Futyma K(2012)Botox(®) for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection Arch Gynecol Obstet 286 923-929
[4]  
Amundsen CL(2012)Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence N Engl J Med 367 1803-1813
[5]  
Richter HE(2020)Best practice statement on urologic procedures and antimicrobial prophylaxis J Urol 203 351-356
[6]  
Menefee SA(2022)PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis Campbell Syst Rev 18 e1230-12
[7]  
Granese R(2016)Rayyan—a web and mobile app for systematic reviews Syst Rev 5 210-88
[8]  
Adile G(1996)Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1-54
[9]  
Gugliotta G(2009)A general framework for the evaluation of clinical trial quality Rev Recent Clin Trials 4 79-654
[10]  
Cucinella G(2016)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions BMJ 355 i4919-1051